Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal Dialysis

Table 2

Selected clinical and biochemical characteristics during patients’ follow-up.

	Baseline	3 months	6 months	value
NYHA class	4.0 (3.0–4.0)	3.0 (3.0–4.0)	3.0 (3.0–4.0)	0.0035
Serum creatinine, mg/dL	2.64 (1.54–5.89)	2.55 (1.36–6.27)	2.28 (1.32–8.11)	0.9907
Serum urea, mg/dL	210 (83–287)	135 (79–194)	143.5 (66–176)	0.0012
Serum sodium, mEq/L	135 (127–142)	134 (125–143)	138 (136–139)	0.1843
Serum uric acid, mg/dL	11.6 (4.5–14)	7.7 (6.3–13.7)	8.7 (7.3–11.6)	0.0585
Serum albumin, g/dL	3.2 (2.8–3.6)	3 (2.5–4.1)	3.3 (2.5–4.0)	0.1148
Serum WBC, 1,000/μL	5.91 (3.36–13.18)	7.05 (3.92–13.7)	7.005 (4.59–11.05)	0.4014
ESR	30 (5–80)	40 (2–75)	30 (2–80)	0.7183

Values are expressed as median and range.